CEO Jodie Morrison was paid $1,558,870 in fiscal year 2025, ↓ down 74.0% from fiscal year 2024 (SEC filing 0001193125-26-193934 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$1,558,870 ↓ Jodie Morrison total, FY2025 | — CEO pay percentile vs peers | — CEO-to-median pay ratio | — Say-on-pay support, latest vote |
Ask our research desk, 24h, every figure cited to its filing.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Jodie Morrison | $645,600 | $0 | $335,280 | $220,792 | $355,080 | $0 | $2,118 | $1,558,870 |
| Chief Executive Officer and Director | ||||||||
| Lee Kalowski | 565,000 | 0 | 135,255 | 59,122 | 226,000 | 0 | 1,770 | 987,147 |
| Chief Financial Officer and President | ||||||||
| Shelia Violette | 455,000 | 0 | 95,250 | 37,312 | 182,000 | 0 | 4,884 | 774,446 |
| Chief Scientific Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Jodie Morrison | $1,558,870 | $6,003,238 | — | ↓ −4,444,368 |
| Lee Kalowski | 987,147 | 2,854,009 | — | ↓ −1,866,862 |
| Shelia Violette | 774,446 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Q32 Bio Inc.'s Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper QTTB reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
This is the complete answer, not a partial one — the list is never padded.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Jodie Morrison | Option | 221,876 | 2.54 | — |
| Jodie Morrison | Option | 34,991 | 2.54 | — |
| Lee Kalowski | Option | 73,941 | 2.54 | — |
| Shelia Violette | RSU | 28,125 | — | 96,750 |
| Shelia Violette | Option | 31,733 | 2.54 | — |
| Lee Kalowski | RSU | 39,938 | — | 137,387 |
| Jodie Morrison | Option | 7,745 | 2.54 | — |
| Jodie Morrison | RSU | 99,000 | — | 340,560 |
| Jodie Morrison | Option | 28,628 | 2.54 | — |
Our executive compensation program consists of a combination of base salary, non-equity incentive compensation and long-term equity incentives. We have designed our compensation program to reflect competitive levels of compensation for comparable positions in the market including among our peer companies, the historical compensation levels, individual performance, and the achievement of our corporate objectives.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon plc |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Mark IwickiIndependent · Board Chair · Audit · Compensation (Chair) · Not standing for re-election | $95,000 | — | $134,443 | — | — | $229,443 |
| Kathleen LaPorteIndependent · Audit (Chair) · Nominating and Corporate Governance | 64,000 | — | 120,096 | — | — | 184,096 |
| Bill Lundberg, M.DIndependent · Compensation · Research and Development (Chair) · Not standing for re-election | 56,000 | — | 123,500 | — | — | 179,500 |
| Mary ThistleIndependent · Audit · Nominating and Corporate Governance (Chair) · Not standing for re-election | 59,500 | — | 118,237 | — | — | 177,737 |
| David Grayzel, M.DIndependent · Research and Development · Not standing for re-election | 45,000 | — | 121,024 | — | — | 166,024 |
| Isaac Manke, Ph.DIndependent · Compensation · Not standing for re-election | 46,000 | — | 119,003 | — | — | 165,003 |
| Arthur Tzianabos, Ph.DNot independent · Research and Development | 45,000 | — | 118,237 | — | — | 163,237 |
| Diyong XuIndependent · Nominating and Corporate Governance · Not standing for re-election | 45,000 | — | 118,237 | — | — | 163,237 |
| Jodie MorrisonEmployee director | — | — | — | — | — | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | $114,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 9,500 / 6,000 / 5,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $455,500 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $455,500 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Q32 Bio Inc. | 2025 | Jodie Morrison | $645,600 | $335,280 | $220,792 | $355,080 | $1,558,870 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Jodie Morrison | DEF 14A | 2026-04-30 | 0001193125-26-193934 | Section “Executive Compensation”. As printed: 1,558,870. Filing ↗machine: r2 · c29 · span 516789–516798 |
| 2 | Section 01, Lee Kalowski | DEF 14A | 2026-04-30 | 0001193125-26-193934 | Section “Executive Compensation”. As printed: 987,147. Filing ↗machine: r4 · c29 · span 538495–538502 |
| 3 | Section 01, Shelia Violette | DEF 14A | 2026-04-30 | 0001193125-26-193934 | Section “Executive Compensation”. As printed: 774,446. Filing ↗machine: r6 · c29 · span 560222–560229 |
| 4 | Section 08, Mark Iwicki | DEF 14A | 2026-04-30 | 0001193125-26-193934 | Section “Director Compensation”. As printed: 229,443. Filing ↗machine: span 405324–405533 |
| 5 | Section 08, Kathleen LaPorte | DEF 14A | 2026-04-30 | 0001193125-26-193934 | Section “Director Compensation”. As printed: 184,096. Filing ↗machine: span 409920–410129 |
| 6 | Section 08, Bill Lundberg, M.D | DEF 14A | 2026-04-30 | 0001193125-26-193934 | Section “Director Compensation”. As printed: 179,500. Filing ↗machine: span 414519–414728 |
| 7 | Section 08, Mary Thistle | DEF 14A | 2026-04-30 | 0001193125-26-193934 | Section “Director Compensation”. As printed: 177,737. Filing ↗machine: span 423709–423918 |
| 8 | Section 08, David Grayzel, M.D | DEF 14A | 2026-04-30 | 0001193125-26-193934 | Section “Director Compensation”. As printed: 166,024. Filing ↗machine: span 400733–400942 |
| 9 | Section 08, Isaac Manke, Ph.D | DEF 14A | 2026-04-30 | 0001193125-26-193934 | Section “Director Compensation”. As printed: 165,003. Filing ↗machine: span 419117–419326 |
| 10 | Section 08, Arthur Tzianabos, Ph.D | DEF 14A | 2026-04-30 | 0001193125-26-193934 | Section “Director Compensation”. As printed: 163,237. Filing ↗machine: span 428312–428521 |
| 11 | Section 08, Diyong Xu | DEF 14A | 2026-04-30 | 0001193125-26-193934 | Section “Director Compensation”. As printed: 163,237. Filing ↗machine: span 432901–433110 |
| 12 | Section 08, Jodie Morrison | DEF 14A | 2026-04-30 | 0001193125-26-193934 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 13 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 14 | Section 09b board cost (computed) | Computed | — | — | Cash 455,500 + equity 0 + all other 0 = 455,500, summed across the director compensation table rows.machine: formula: Σ = 455,500 |
| 15 | Q32 Bio Inc. (subject), Section 10b CEO total | DEF 14A | 2026-04-30 | 0001193125-26-193934 | CEO total compensation as printed in Q32 Bio Inc.'s own proxy. As printed: 1,558,870. Filing ↗machine: r2 · c29 · span 516789–516798 |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat